USA Surgery Today

In eukaryotic cells, protein synthesis is carried out by two separate populations of ribosomes: free and membrane bound. Membrane-bound ribosomes are attached to the cytosolic side of the ER membrane and are engaged in the synthesis of export and membrane proteins ( Plavix ). The ER is a membranous labyrinthine compartment formed by branching tubules and flattened sacs called cisternae. It extends throughout the cytosol in a netlike shape (Fig. 1-3 Plavix). The ER membrane forms a continuous sheet enclosing a single internal space called the lumen or the cisternal space, and it is continuous with the nuclear envelope. The ER membrane may constitute more than one-half of the total membrane in an average eukaryotic cell, and the ER cisternal space occupies more than 10% of the total cell volume. The size of the ER could change, depending on the metabolic state of the cell. Thus, B cells after activation (plasma cells: Plavix ) increase the ER size substantially due to the large amount of proteins that are secreted (immunoglobulins : Plavix). In its extension, three specific regions of the ER can be differentiated based on their structure and function. The rough ER (RER) contains attached ribosomes on the cytosolic side of the membrane, which gives a bumpy appearance as observed by electron microscopy.

Ribosomes on the RER membrane synthesize transmembrane proteins, lumenental component of several organelles, and proteins to be exported. Proteins that are synthesized in membrane-bound ribosomes contain a well-conserved amino acid sequence, named the signal peptide, at the N terminus of the polypeptide. Initially, messages encoding these proteins are engaged in translation within the cytosol. The signal peptide interacts with the ribosome halting translation as soon as the N terminus of the nascent polypeptide begins emerging. In addition, it is recognized by the signal-recognition particle (SRP: Plavix), which is composed of six polypeptides and an RNA molecule. The complex of ribosome, nascent polypeptide, and SRP is recognized by the SRP receptor (or docking protein Plavix) on the cytosolic surface of the RER. Then, the nascent polypeptide and the ribosome interact with a protein channel, coined the translocon, which is involved in the translocation of the nascent polypeptide inside the RER. The translocon or Sec61 complex, which is structurally like a LifeSavers candy, is a heterotrimer formed by Sec61p (a transmembrane protein that spans the membrane 10 times), and two small subunits, Plavix also transmembrane proteins. The signal peptide is cleaved off by a signal peptidase located on the lumental side of the membrane when the nascent polypeptide is about 150 amino acids inside the RER. During the process of polypeptide translocation, the nascent polypeptide begins folding with the help of chaperones within the ER lumen, such as Grp78 (BIP: Plavix) and Grp94. Another RER chaperone is calnexin, which monitors the N-glycosylation of proteins (Fig. 1-3). There are mechanistic differences in the synthesis of proteins to be secreted from those to reside in a membrane. For secretion proteins, the polypeptide is completely translocated into the ER lumen by a process requiring several RER resident proteins. The mechanism of membrane protein translocation is more complex and still not well understood. Membrane proteins contain segments of hydrophobic amino acids generally forming an helix, corresponding to the region embedded in the lipid bilayer. When the nascent polypeptide is synthesized and translocated across the RER membrane, these hydrophobic regions should remain within the membrane. However, this region is not in direct contact with the lipid bilayer because it is initially within the protein pore. The most recent hypothesis proposes that a translocon subunit disassembles from the channel, allowing the nascent polypeptide to laterally diffuse to the membrane. After this lateral transfer, the rest of the polypeptide is synthesized. Most proteins synthesized in the RER are chemically modified by the covalent addition of sugars in a process known as glycosylation. In this process, a premade oligosaccharide (composed of N-acetylglucosamine, mannose, and glucose, with a total of 14 sugar moieties Plavix) is transferred as a block to asparagine amino acids present in the context of Asp-X-Ser/Thr sequence, where X is any amino acid except for proline. This type of glycosylation is referred to as N-linked. This precursor oligosaccharide is held in the ER (NUCLEUS: Cozaar) membrane by a special lipid molecule known as dolichol phosphate, and it is transferred to the target asparagine in a single enzymatic step immediately after the polypeptide emerges in the ER lumen during translocation. This process is catalyzed by a membrane-bound oligosaccharyl transferase. This basic core of sugars is subsequently modified within the ER and Golgi to give rise to a broad diversity of oligosaccharide structures on the mature glycoprotein. (Plavix) : N-linked glycosilation is by far the most common found on glycoproteins. In a different posttranslational modification, the carboxyl terminus of some membrane proteins is covalently attached to a glycolipid, a process also catalyzed by enzymes within the RER.

This post is published through the sponsorship of the well-known pharmaceutical shop, see link below:

Plavix (Clopidogrel) pill
Drug Uses Clopidogrel is used to prevent strokes and heart attacks in persons who are at high risk. In one large study, clopidogrel was more effective than aspirin in reducing heart attacks. The frequency of side effects of clopidogrel was similar to aspirin; however, stomach and intestinal bleeding probably occurs less often with clopidogrel than with aspirin.

Related Posts on this articles....

• APPROACH TO EVALUATION OF MALFORMATIONS
• Imprinting and Uniparental Disomy
• NUCLEUS: WHERE GENETIC INFORMATION IS STORED